ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)

Volume 13, 12 Issues, 2016

Download PDF Flyer

Current Alzheimer Research

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 59st of 192 in Clinical Neurology
  • 101st of 256 in Neurosciences

Submit Abstracts Online Submit Manuscripts Online

Prof. Debomoy K. Lahiri
Department of Psychiatry, Indiana University School of Medicine
Neuroscience Research Center
Indianapolis, IN 46202

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.145
5 - Year: 3.58

Upcoming Articles (E-Pub Abstracts ahead of Print)

Nanocapsulated Ascorbic Acid in Combating Cerebral Ischemia Reperfusion-Induced Oxidative Injury in Rat Brain

Abhishek Mukherjee, Sibani Sarkar, Snehasikta Swarnakar and Nirmalendu Das.

View Abstract

Targeting Ras Activity Prevented Amyloid Beta-Induced Aberrant Neuronal Cell Cycle Re-Entry and Death

Murat Köseoğlu, Bağdeser Akdoğan Özdilek, Umidahan Djakbarova and Ayse Gülüsürc.

View Abstract

The long non-coding RNAs in neurodegenerative diseases: novel mechanisms of pathogenesis

Paola Riva, Antonia Ratti and Marco Venturin.

View Abstract

Attitudinal & Knowledge Barriers towards Effective Pain Assessment & Management in Dementia: A Narrative Synthesis.

Rebecca C. Chandler, Sandra MG Zwakhalen, Rachael Docking, Benjamin Bruneau and Patricia Schofield.

View Abstract

Orofacial pain and Mastication in Dementia

Frank Lobbezoo, Suzanne Delwel, Roxane A.F. Weijenberg and Erik JA Scherder.

View Abstract

Alzheimer’s Disease is Associated with Increased Risk of Osteoporosis: The Chongqing Aging Study

Dong Liu, Huadong Zhou, Yong Tao, Jun Tan, Lin Chen, Haiyang Huang, Yang Chen, Yafei Li and Rui Zhou.

View Abstract View on PubMed

Role of Artificial Intelligence Techniques (Automatic Classifiers) in Molecular Imaging Modalities in Neurodegenerative Diseases

Silvia Cascianelli, Michele Scialpi, Serena Amici, Nevio Forini, Matteo Minestrini, Mario Luca Fravolini, Helmut Sinzinger, Orazio Schillaci and Barbara Palumbo.

View Abstract

Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer’s Disease

Ryuichi Takahashi, Kazunari Ishii and Kazumasa Yokoyama.

View Abstract

18F-Labeled 2-Arylquinoline Derivatives for Tau Imaging: chemical, radiochemical, biological and clinical features

Shozo Furumoto, Tetsuro Tago, Ryuichi Harada, Yukitsuka Kudo and Nobuyuki Okamura.

View Abstract

Usefulness of 18F Florbetaben in diagnosis of Alzheimer’s disease and other types of dementia

Agostino Chiaravalloti, Roberta Danieli, Annamaria Lacanfora, Barbara Palumbo, Carlo Caltagirone and Orazio Schillaci.

View Abstract

FDG PET/MR imaging in major neurocognitive disorders

C. Ismini Mainta, Daniela Perani, M.A. Bénédicte Delattre, Frédéric Assal, Sven Haller, I. Maria Vargas, S. Dina Zekry, B. Giovanni Frisoni, Habib Zaidi, Osman Ratib and Valentina Garibotto.

View Abstract

Non-amyloid PET imaging biomarkers for neurodegeneration: Focus on tau, alpha-synuclein and neuroinflamation

Ana M. Catafau and Santiago Bullich.

View Abstract

Drug Development of Small-Molecule Inhibitors of AD-Relevant Kinases as Novel Perspective Multitargeted Approach

V. Tell, I. Hilbrich, M. Holzer, Frank Totzke, Christoph Schächtele, Ina Slynko, Wolfgang Sippl and A Hilgeroth.

View Abstract

Serum insulin degrading enzyme level and other factors in type 2 diabetic patients with mild cognitive impairment

Jie Sun, Wenqing Xia, Rongrong Cai, Pin Wang, Rong Huang, Haixia Sun, Sai Tian, Xue Dong and Shaohua Wang.

View Abstract

Neuroimaging findings related to behavioral disturbances in Alzheimer’s disease: a systematic review

Gilberto Sousa Alves, André Férrer Carvalho, Luiza de Amorim de Carvalho, Felipe Kenji Sudo, José Ibiapina Siqueira-Neto, Alina Jurcoane, Christian Knöchel, Henning Boecker, Jerson Laks and Johannes Pantel.

View Abstract

The brainstem tau cytoskeletal pathology of Alzheimer’s disease: A brief historical overview and description of its anatomical distribution pattern, evolutional features, pathogenetic and clinical relevance

Udo Rüb, Katharina Stratmann, Helmut Heinsen, Domenico Del Turco, Kay Seidel, Wilfred den Dunnen and Horst-Werner Korf.

View Abstract

Integrated biomarkers for depression in Alzheimer’s disease: a critical review

Sofia Wenzlera, Christian Knöchela, Ceylan Balabana, Dominik Krafta, Juliane Kopfa, Gilberto S. Alves, David Prvulovica, André F. Carvalho and Viola Oertel-Knöch.

View Abstract

Facial pain expression in dementia: a review of the experimental and clinical evidence

Stefan Lautenbacher and Miriam Kunz.

View Abstract

Lack of association between genetic polymorphism of circadian genes (PER2, PER3, CLOCK and OX2R) with late onset depression and Alzheimer's disease in a sample of a Brazilian population (Circadian Genes, Late-Onset Depression and Alzheimer's Disease)

Patricia Araújo Pereira, António Alvim-Soares, Maria Aparecida Camargos Bicalho, Edgar Nunes de Moraes, Leandro Malloy-Diniz, Jonas Jardim de Paula, Marco Aurélio Romano-Silva and Debora Marques Miranda.

View Abstract

The association between alcohol useand the progression of Alzheimer’s disease

Devorah Heymann, Yaakov Stern, Stephanie Cosentino, Oksana Tatarina-Nulman, Jhedy N. Dorrejo and Yian Gu.

View Abstract

Ceramide and sphingosine-1-phosphate in cell death pathways: Relevance to the pathogenesis of Alzheimer's disease

Sankha Shubhra Chakrabarti, Aritri Bir, Jit Poddar, Maitrayee Sinha, Anirban Ganguly and Sasanka Chakrabarti.

View Abstract

Alzheimer’s disease and the early signs of age-related macular degeneration

Shaun Frost, Robyn Guymer, Khin Zaw Aung, S. Lance Macaulay, Hamid R Sohrabi, Pierrick Bourgeat, Olivier Salvado, Christopher C. Rowe, David Ames, Colin L. Masters, Ralph N. Martins, Yogesan Kanagasingam and and the AIBL Research Group.

View Abstract

MCI patients in Europe: Medication and comorbidities. The DESCRIPA study

Magda Tsolaki, Vasileios Papaliagkas, Giovanni Frisoni, Roy Jones, Jacques Touchon, Luiza Spiru, Bruno Vellaz, Frans Verhey, Bengt Winblad and Pieter Jelle Visser.

View Abstract

Rescue of Hypovitaminosis A induces non-amyloidogenic Amyloid Precursor Protein (APP) Processing

Sven Reinhardt, Marcus O.W. Grimm, Christoph Stahlmann, Tobias Hartmann, Koichi Shudo, Taisuke Tomita and Kristina Endres.

View Abstract

LW-AFC, a herbal medicine for Alzheimer’s disease, ameliorates cognitive deterioration and modulates neuroendocrine-immune system in senescence-accelerated mouse prone 8 strain

Jianhui Wang, Xiaorui Zhang, Xiaorui Cheng, Junping Cheng, Feng Liu, Yiran Xu, Ju Zeng, Shanyi Qiao, Wenxia Zhou and Yongxiang Zhang.

View Abstract


Franca Tecchio, Fabrizio Vecchio, Mariacarla Ventriglia, Camillo Porcaro, Francesca Miraglia, Mariacristina Siotto, Paolo M. Rossini, Mauro Rongioletti and Rosanna Squitti.

View Abstract

Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer’s Disease – A Mini-Review

Blanka Klimova and Kamil Kuca.

View Abstract

Involvement of the septo-hippocampal cholinergic pathway in association with septal acetylcholinesterase upregulation in a mouse model of tauopathy

Yuko Hara, Yumiko Motoi, Keigo Hikishima, Hiroshi Mizum, Hirotaka Onoe, Shin-Ei Matsumoto, Montasir Elahi, Hideyuki Okano, Shigeki Aoki and Nobutaka Hattori.

View Abstract

Omega-3 fatty acids: repurposing opportunities for cognition and biobehavioral disturbances in MCI and Dementia

Christian Knöchel, Martin Voss, Florian Grüter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stäblein, Dominik Kraft, David Prvulovic, André F. Carvalho, Andreas Reif and Viola Oertel-Knöchel.

View Abstract

Joint occurrence of pain and sleep disturbances in people with dementia A systematic review

Elisabeth Flo, Bjørn Bjorvatn, Anne Corbett, Ståle Pallesenc and Bettina S Husebo.

View Abstract

Observation of Pain in Dementia

Keela Herr, Sandra Zwakhalen and Kristen Swafford.

View Abstract

Pain experience in Dementia Subtypes: A Systematic Review

TT Binnekade, Van Kooten Jb, F Lobbezoo, D Rhebergen, Van der Wouden JC, M Smalbrugge and EJA Scherder.

View Abstract

Glucagon-Like Peptide-1-Mediated Modulation of Inflammatory Pathways in the Diabetic Brain: Relevance to Alzheimer’s Disease

LiMei Qin, Thomas Chong, Richard Rodriguez and Subbiah Pugazhenthi.

View Abstract View on PubMed

Inflammation, Oxidation, Caloric Expenditure and Cognitive Impairment in Brazilian Elderly Assisted at Primary Care

Guilherme Marcos Nogueira, Carla Helena Augustin Schwanke, Vera Elizabeth Closs, Bruna Luz, Rafael Noal Moresco, Etiane Tatsch, Guilherme Vargas Bochi, João Feliz Duarte de Moraes, Camila Bittencourt Jacondino, Irenio Gomes and Maria Gabriela Valle Gottlieb.

View Abstract

Substance P and Alzheimer’s disease: emerging novel roles

Severini Cinzia, Petrella Carla and Calissano Pietro.

View Abstract

Can Diet and Physical Activity limit Alzheimer’s disease Risk?

Shraddha D. Rege, Thangiah Geetha, Tom L. Broderick and Jeganathan Ramesh Babu.

View Abstract


Related Journals

Related eBooks

Webmaster Contact: Copyright © 2016 Bentham Science